Pharming Group N.V. (PHAR) stock
PHARNasdaqPharmaceutical PreparationsFiscal year ends December 31
$12.95−0.45 (-3.36%)
Close on Nov 12, 2026Market cap $908.68MP/E 323.8Yield –
Pharming EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
For fiscal 2025 it was $0.00. The highest annual figure on record is $0.06 in fiscal 2019.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.00 | – |
| FY2024 | Dec 31, 2024 | -$0.02 | – |
| FY2023 | Dec 31, 2023 | -$0.02 | -184.2% |
| FY2022 | Dec 31, 2022 | $0.02 | -17.4% |
| FY2021 | Dec 31, 2021 | $0.02 | -58.2% |
| FY2020 | Dec 31, 2020 | $0.06 | -8.3% |
| FY2019 | Dec 31, 2019 | $0.06 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?